Avalo Therapeutics, Inc. · NASDAQ:AVTX

Orbimed Advisors LLC reported a 8.90% stake in Avalo Therapeutics, Inc. (Schedule 13G/A)

Event Jun 30, 2025 · Filed Aug 14, 2025

Orbimed Advisors LLC reported a 8.90% stake in Avalo Therapeutics, Inc., 967,000 shares, as a passive investor on Jun 30, 2025. Filed Aug 14, 2025 (Schedule 13G/A).

Stake
8.90%
Shares
967,000
Intent
Passive
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
OrbiMed Advisors LLC8.90%967,000
OrbiMed Capital GP IX LLC6.00%644,667

Source

View original at SEC

Related